|
FR2470599A1
(fr)
|
1979-12-07 |
1981-06-12 |
Panoz Donald |
Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
|
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
|
US5026560A
(en)
|
1987-01-29 |
1991-06-25 |
Takeda Chemical Industries, Ltd. |
Spherical granules having core and their production
|
|
US5000886A
(en)
|
1987-05-26 |
1991-03-19 |
American Cyanamid Company |
Silicone-hardened pharmaceutical microcapsules and process of making the same
|
|
US5122519A
(en)
|
1989-06-27 |
1992-06-16 |
American Cyanamid Company |
Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
|
|
JPH0624959A
(ja)
|
1991-10-04 |
1994-02-01 |
Bayer Yakuhin Kk |
胃内浮遊型薬物徐放性固形製剤
|
|
US5538954A
(en)
|
1994-06-24 |
1996-07-23 |
A/S Dumex (Dumex Ltd.) |
Salts of tetracyclines
|
|
US6077533A
(en)
|
1994-05-25 |
2000-06-20 |
Purdue Pharma L.P. |
Powder-layered oral dosage forms
|
|
US5411745A
(en)
|
1994-05-25 |
1995-05-02 |
Euro-Celtique, S.A. |
Powder-layered morphine sulfate formulations
|
|
CN1132566C
(zh)
|
1994-12-16 |
2003-12-31 |
沃尼尔·朗伯公司 |
在胶囊中填充囊芯的方法和由该方法制得的固体剂型
|
|
US6245350B1
(en)
|
1994-12-16 |
2001-06-12 |
Warner-Lambert Company |
Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process
|
|
JPH0995440A
(ja)
|
1995-09-29 |
1997-04-08 |
Roussel Morishita Kk |
徐放性製剤およびその製造方法
|
|
AUPN814496A0
(en)
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
|
EP0910348B1
(en)
|
1996-05-23 |
2003-04-02 |
Samyang Corporation |
Locally administrable, biodegradable and sustained-release pharmaceutical composition for periodontitis and process for preparation thereof
|
|
US5789395A
(en)
|
1996-08-30 |
1998-08-04 |
The Research Foundation Of State University Of New York |
Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
|
|
US5780055A
(en)
|
1996-09-06 |
1998-07-14 |
University Of Maryland, Baltimore |
Cushioning beads and tablet comprising the same capable of forming a suspension
|
|
US8137684B2
(en)
|
1996-10-01 |
2012-03-20 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US8828432B2
(en)
|
1996-10-28 |
2014-09-09 |
General Mills, Inc. |
Embedding and encapsulation of sensitive components into a matrix to obtain discrete controlled release particles
|
|
US6635280B2
(en)
|
1997-06-06 |
2003-10-21 |
Depomed, Inc. |
Extending the duration of drug release within the stomach during the fed mode
|
|
ES2248908T7
(es)
|
1997-06-06 |
2014-11-24 |
Depomed, Inc. |
Formas de dosificación de fármacos por vía oral y retención gástrica para liberación continuada de fármacos altamente solubles
|
|
PL337813A1
(en)
|
1997-06-11 |
2000-09-11 |
Procter & Gamble |
Coated tablet with a coating ensuring safe administration for upper portion of the gastrointestinal tract
|
|
PE20000601A1
(es)
|
1998-03-23 |
2000-07-25 |
Gen Mills Inc |
Encapsulado de componentes en productos comestibles
|
|
US7201923B1
(en)
|
1998-03-23 |
2007-04-10 |
General Mills, Inc. |
Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles
|
|
ES2326502T3
(es)
|
1998-10-09 |
2009-10-13 |
General Mills, Inc. |
Encapsulacion de componentes liquidos sensibles en una matriz para obtener particulas discretas de larga conservacion.
|
|
US7374779B2
(en)
|
1999-02-26 |
2008-05-20 |
Lipocine, Inc. |
Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
|
|
CA2367373C
(en)
|
1999-03-17 |
2011-09-20 |
Daiichi Pharmaceutical Co., Ltd. |
Medicinal compositions
|
|
US20030077301A1
(en)
|
1999-12-16 |
2003-04-24 |
Maibach Howard I. |
Topical pharmaceutical composition for the treatment of inflammatory dermatoses
|
|
DZ3227A1
(fr)
|
1999-12-23 |
2001-07-05 |
Pfizer Prod Inc |
Compositions pharmaceutiques fournissant des concentrations de medicaments ameliorees
|
|
US6730320B2
(en)
|
2000-02-24 |
2004-05-04 |
Advancis Pharmaceutical Corp. |
Tetracycline antibiotic product, use and formulation thereof
|
|
US6544555B2
(en)
|
2000-02-24 |
2003-04-08 |
Advancis Pharmaceutical Corp. |
Antibiotic product, use and formulation thereof
|
|
US6638532B2
(en)
|
2000-02-24 |
2003-10-28 |
Advancis Pharmaceutical Corp. |
Tetracycline—doxycycline antibiotic composition
|
|
FR2811571B1
(fr)
|
2000-07-11 |
2002-10-11 |
Flamel Tech Sa |
Composition pharmaceutique orale, permettant la liberation controlee et l'absorption prolongee d'un principe actif
|
|
RU2281757C2
(ru)
*
|
2000-09-19 |
2006-08-20 |
Дайити Фармасьютикал Ко., Лтд. |
Фармацевтическая композиция
|
|
US6497901B1
(en)
|
2000-11-02 |
2002-12-24 |
Royer Biomedical, Inc. |
Resorbable matrices for delivery of bioactive compounds
|
|
UA80393C2
(uk)
|
2000-12-07 |
2007-09-25 |
Алтана Фарма Аг |
Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
|
|
IN192750B
(enExample)
|
2000-12-15 |
2004-05-15 |
Ranbaxy Lab Ltd |
|
|
US7211267B2
(en)
|
2001-04-05 |
2007-05-01 |
Collagenex Pharmaceuticals, Inc. |
Methods of treating acne
|
|
AU2002256092C1
(en)
|
2001-04-05 |
2009-10-15 |
Collagenex Pharmaceuticals, Inc. |
Controlled delivery of tetracycline compounds and tetracycline derivatives
|
|
CA2409552A1
(en)
|
2001-10-25 |
2003-04-25 |
Depomed, Inc. |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
|
US20030091630A1
(en)
|
2001-10-25 |
2003-05-15 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
|
|
US20030104052A1
(en)
|
2001-10-25 |
2003-06-05 |
Bret Berner |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
|
JP2005523309A
(ja)
|
2001-12-20 |
2005-08-04 |
アドバンシス ファーマスーティカル コーポレイション |
抗生物質産物、その使用法と製剤
|
|
KR100540035B1
(ko)
|
2002-02-01 |
2005-12-29 |
주식회사 태평양 |
다단계 경구 약물 방출 제어 시스템
|
|
JP2005526059A
(ja)
|
2002-03-07 |
2005-09-02 |
アドバンシス ファーマスーティカル コーポレイション |
抗生物質組成物
|
|
US6958161B2
(en)
|
2002-04-12 |
2005-10-25 |
F H Faulding & Co Limited |
Modified release coated drug preparation
|
|
AUPS167602A0
(en)
|
2002-04-12 |
2002-05-16 |
F.H. Faulding & Co. Limited |
An improved modified release preparation
|
|
CA2476792A1
(en)
|
2002-04-16 |
2003-10-30 |
Collagenex Pharmaceuticals, Inc. |
Methods of simultaneously treating ocular rosacea and acne rosacea
|
|
US8192749B2
(en)
|
2003-04-16 |
2012-06-05 |
Galderma Laboratories Inc. |
Methods of simultaneously treating ocular rosacea and acne rosacea
|
|
WO2004000276A1
(en)
|
2002-06-20 |
2003-12-31 |
Royer Biomedical, Inc. |
Resorbable matrices with coatings for delivery of bioactive compounds
|
|
PT1532985T
(pt)
|
2002-06-25 |
2017-01-20 |
Takeda Pharmaceuticals Co |
Processo de produção de uma composição de libertação sustentada
|
|
US8216609B2
(en)
|
2002-08-05 |
2012-07-10 |
Torrent Pharmaceuticals Limited |
Modified release composition of highly soluble drugs
|
|
US7820145B2
(en)
|
2003-08-04 |
2010-10-26 |
Foamix Ltd. |
Oleaginous pharmaceutical and cosmetic foam
|
|
EP1417958A1
(en)
|
2002-11-08 |
2004-05-12 |
Pari GmbH |
Wet granulation process
|
|
EP1589951B1
(en)
|
2003-01-03 |
2017-08-09 |
Supernus Pharmaceuticals, Inc. |
Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics
|
|
US20040185097A1
(en)
|
2003-01-31 |
2004-09-23 |
Glenmark Pharmaceuticals Ltd. |
Controlled release modifying complex and pharmaceutical compositions thereof
|
|
EP1613333A1
(en)
|
2003-04-04 |
2006-01-11 |
Pharmacia Corporation |
Oral extended release compressed tablets of multiparticulates
|
|
CA2894736C
(en)
|
2003-04-07 |
2019-07-16 |
Supernus Pharmaceuticals, Inc. |
Once daily formulations of tetracyclines
|
|
US20040202693A1
(en)
|
2003-04-14 |
2004-10-14 |
Rong-Kun Chang |
Pharmaceutical compositions releasing their active agents from a buccal or sublingual location to overcome an absorption window problem
|
|
US20070110804A1
(en)
|
2003-06-20 |
2007-05-17 |
Royer Biomedical, Inc. |
Drug polymer complexes
|
|
NZ544826A
(en)
|
2003-07-25 |
2008-07-31 |
Warner Chilcott Co Inc |
A doxycycline metal complex in a solid dosage form
|
|
WO2005016311A1
(en)
|
2003-08-11 |
2005-02-24 |
Advancis Pharmaceutical Corporation |
Robust pellet
|
|
US20050049210A1
(en)
|
2003-08-27 |
2005-03-03 |
Idexx Laboratories, Inc. |
Methods for the controlled delivery of pharmacologically active compounds
|
|
KR101148013B1
(ko)
|
2003-10-27 |
2012-07-05 |
다니스코 유에스 인크. |
국소용 제제, 및 활성제를 기재로 전달하는 방법
|
|
WO2005046651A1
(en)
|
2003-11-12 |
2005-05-26 |
Ranbaxy Laboratories Limited |
Liquid filled capsules of doxycycline
|
|
JP2007513145A
(ja)
|
2003-12-04 |
2007-05-24 |
ファイザー・プロダクツ・インク |
医薬用多微粒子の製造方法
|
|
DE10358748A1
(de)
|
2003-12-12 |
2005-07-14 |
Lts Lohmann Therapie-Systeme Ag |
Darreichungsform basierend auf vernetzten hydrophilen Polymeren
|
|
US7410480B2
(en)
|
2004-04-21 |
2008-08-12 |
Acclarent, Inc. |
Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders
|
|
EP1758557B1
(en)
|
2004-05-11 |
2011-07-13 |
Egalet Ltd. |
Swellable dosage form comprising gellan gum
|
|
CN101005828B
(zh)
|
2004-06-17 |
2012-01-11 |
维尔恩公司 |
用于经粘膜递送活性成分的包含粘膜粘附蛋白和所述活性物质的组合物
|
|
US20080161273A1
(en)
|
2004-10-20 |
2008-07-03 |
Galderma Research & Development |
Method of Using Adapalene in Acne Maintenance Therapy
|
|
US8715724B2
(en)
|
2004-10-29 |
2014-05-06 |
Mayne Pharma International Pty Ltd |
Tabletting process
|
|
US20060147491A1
(en)
|
2005-01-05 |
2006-07-06 |
Dewitt David M |
Biodegradable coating compositions including multiple layers
|
|
US9205047B2
(en)
|
2005-04-25 |
2015-12-08 |
The Governing Council Of The University Of Toronto |
Tunable sustained release of a sparingly soluble hydrophobic therapeutic agent from a hydrogel matrix
|
|
US20060280795A1
(en)
|
2005-06-08 |
2006-12-14 |
Dexcel Pharma Technologies, Ltd. |
Specific time-delayed burst profile delivery system
|
|
US20100215744A1
(en)
|
2008-08-06 |
2010-08-26 |
Medicis Pharmaceutical Corporation |
Hydroxypropyl Substitution Used to Regulate Dissolution of a Chemical
|
|
US20080242642A1
(en)
|
2007-04-02 |
2008-10-02 |
Medicis Pharmaceutical Corporation |
Minocycline oral dosage forms for the treatment of acne
|
|
EP1898886B1
(en)
|
2005-07-01 |
2019-09-04 |
Rubicon Research Pvt Ltd. |
Novel sustained release dosage form
|
|
AU2006264407B2
(en)
|
2005-07-04 |
2012-08-30 |
Ramu Krishnan |
Improved drug or pharmaceutical compounds and a preparation thereof
|
|
WO2007052289A2
(en)
|
2005-07-22 |
2007-05-10 |
Rubicon Research Pvt Ltd. |
Novel dispersible tablet composition
|
|
ZA200802602B
(en)
|
2005-08-24 |
2009-10-28 |
Rubicon Res Pvt Ltd |
Controlled release formulation
|
|
FR2891459B1
(fr)
|
2005-09-30 |
2007-12-28 |
Flamel Technologies Sa |
Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
|
|
WO2007038867A1
(en)
|
2005-10-04 |
2007-04-12 |
Mistral Pharma Inc. |
Controlled-release oral dosage form
|
|
US8906392B2
(en)
|
2005-12-16 |
2014-12-09 |
University Of Kansas |
Nanocluster compositions and methods
|
|
US9078811B2
(en)
|
2006-01-24 |
2015-07-14 |
Paratek Pharmaceuticals, Inc. |
Methods of increasing oral bioavailability of tetracyclines
|
|
WO2007112581A1
(en)
|
2006-04-03 |
2007-10-11 |
Isa Odidi |
Controlled release delivery device comprising an organosol coat
|
|
CA2651798C
(en)
|
2006-05-09 |
2015-07-21 |
Mallinckrodt Inc. |
Zero-order modified release solid dosage forms
|
|
CA2655596C
(en)
|
2006-06-27 |
2011-10-25 |
Biovail Laboratories International Srl |
Multiparticulate osmotic delivery system
|
|
US20080014257A1
(en)
|
2006-07-14 |
2008-01-17 |
Par Pharmaceutical, Inc. |
Oral dosage forms
|
|
US20080268045A1
(en)
|
2006-11-09 |
2008-10-30 |
Proprius Pharmaceuticals, Inc. |
Sustained release methotrexate formulations and methods of use thereof
|
|
PT2120963T
(pt)
|
2006-12-21 |
2018-12-17 |
Paratek Pharm Innc |
Compostos tetraciclina substituídos para tratamento de distúrbios inflamatórios da pele
|
|
GB0703627D0
(en)
|
2007-02-24 |
2007-04-04 |
Agt Sciences Ltd |
Aqueous formulations
|
|
US20100016322A1
(en)
|
2007-02-28 |
2010-01-21 |
Nagesh Nagaraju |
Water Dispersible Pharmaceutical Formulation and Process for Preparing The Same
|
|
KR20090122994A
(ko)
|
2007-03-23 |
2009-12-01 |
몰레큘러 리서치 센터, 인크. |
테트라사이클린류를 함유하는 항염증성 조성물 및 이의 치료 용도
|
|
CN101772341A
(zh)
|
2007-07-11 |
2010-07-07 |
陶氏康宁公司 |
用于递送药物的组合物
|
|
CN101380474B
(zh)
|
2007-09-06 |
2012-07-25 |
北京大学 |
用于口服制剂的pH敏感性固体药物组合物及制备方法
|
|
US20090181068A1
(en)
|
2008-01-14 |
2009-07-16 |
Dunn Richard L |
Low Viscosity Liquid Polymeric Delivery System
|
|
EP2133071A1
(en)
|
2008-06-09 |
2009-12-16 |
Université de la Méditerranée |
Process for making gastroretentive dosage forms
|
|
JP5681626B2
(ja)
|
2008-07-14 |
2015-03-11 |
ポリーペイド リミテッドＰｏｌｙｐｉｄ Ｌｔｄ． |
徐放性薬剤キャリア組成物
|
|
US20110268807A1
(en)
|
2008-08-04 |
2011-11-03 |
James Su |
Biodegradable Microspheres and Methods of Use Thereof
|
|
WO2010033800A2
(en)
|
2008-09-19 |
2010-03-25 |
Alacrity Biosciences, Inc. |
Tetracycline stabilizing formulations
|
|
EP2346351B1
(en)
|
2008-09-22 |
2019-07-03 |
Rubicon Research Private Limited |
Compositions exhibiting delayed transit through the gastrointestinal tract
|
|
DE102008048729A1
(de)
|
2008-09-24 |
2010-03-25 |
Add Technologies Ltd Advanced Drug Delivery |
Multipartikuläre Tabletten und Verfahren zur deren Herstellung
|
|
US20110268666A1
(en)
|
2008-09-29 |
2011-11-03 |
Yissum Research Development Company of the Research University of Jerusalem, Ltd. |
Novel gastroretentive delivery system
|
|
KR20170048606A
(ko)
|
2008-10-02 |
2017-05-08 |
바이엘 컨수머 케어 악티엔게젤샤프트 |
증강된 항미생물 펩티드 및 단백질 수준과 관련된 피부 질환 또는 장애를 치료 또는 완화하기 위한 조성물
|
|
WO2010038234A1
(en)
|
2008-10-02 |
2010-04-08 |
Taro Pharmaceutical Industries Ltd. |
Combination product of spironolactone and doxycycline
|
|
WO2010066203A1
(en)
|
2008-12-10 |
2010-06-17 |
Anhui Zhongren Technology Co., Ltd. |
Controlled releasing composition
|
|
WO2010075065A2
(en)
|
2008-12-15 |
2010-07-01 |
Banner Pharmacaps, Inc. |
Methods for enhancing the release and absorption of water insoluble active agents
|
|
US20120045504A1
(en)
|
2009-04-14 |
2012-02-23 |
Kathryn Whitehead |
oral drug devices and drug formulations
|
|
GB0907019D0
(en)
|
2009-04-24 |
2009-06-03 |
Oxford Nutrascience Ltd |
Pharmaceutical,therapeutic or nutritional delivery systems for functional ingredients
|
|
US20100291201A1
(en)
|
2009-05-14 |
2010-11-18 |
Cerovene, Inc. |
Coated pharmaceutical capsule dosage form
|
|
CA2766912A1
(en)
|
2009-05-28 |
2010-12-02 |
Northwestern University |
Nanodiamond particle complexes
|
|
EP3144004A1
(en)
|
2009-10-06 |
2017-03-22 |
Scott Dorfner |
Antibiotic formulations providing reduced gastrointestinal side effects and clostridium difficile infection relapse, and related methods
|
|
EP2493474B1
(en)
|
2009-10-30 |
2019-09-04 |
Intratus, Inc. |
Methods and compositions for sustained delivery of drugs
|
|
US9327105B2
(en)
|
2010-03-26 |
2016-05-03 |
Itrace Biomedical Inc. |
Active transdermal drug delivery system and the method thereof
|
|
US20120076766A1
(en)
|
2010-04-21 |
2012-03-29 |
Phillips D Howard |
Topical drug delivery system with dual carriers
|
|
CA2802041A1
(en)
|
2010-06-11 |
2011-12-15 |
Precision Dermatology, Inc. |
High oil-content emollient aerosol foam compositions
|
|
WO2012059338A1
(en)
|
2010-10-21 |
2012-05-10 |
Galderma S.A. |
Sustained-release tablet and process for preparing the same
|
|
US8652516B1
(en)
|
2013-03-15 |
2014-02-18 |
Cerovene, Inc. |
Doxycycline formulations, and methods of treating rosacea
|